Drug intelligence / Profile preview

NeuroPro

Development stage: Unknown
Lead developer: NeuroPro Therapeutics
Modality: Small Molecules
Administration: Oral

Overview

NeuroPro is a natural health supplement developed by Neurodyn Life Sciences (formerly Neurodyn Inc.) and licensed to LifeSci Brands Inc. for marketing. It is a standardized extract of *Panax ginseng* formulated to contain a 10% concentration of triterpenoid saponins, delivering 45mg of bioactive ginsenosides per capsule. The product is designed to support cognitive function, enhance mental performance, and improve physical capacity, particularly for individuals seeking to maintain brain health as they age. NeuroPro is classified as a consumer natural health product and has received a product license from Health Canada (NPN 80036879).

Brand names: NeuroPro

Beyond the preview

Go deeper on NeuroPro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroPro.

Explore the full profile